Dolphin Medical Services Ltd
Incorporated in 1984, Dolphin Medical Services Ltd is in the business of diagnostics and
other allied services.[1]
- Market Cap ₹ 11.4 Cr.
- Current Price ₹ 7.52
- High / Low ₹ 7.52 / 1.98
- Stock P/E
- Book Value ₹ 8.45
- Dividend Yield 0.00 %
- ROCE -0.05 %
- ROE -0.39 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.89 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -32.5% over past five years.
- Promoter holding is low: 26.4%
- Company has a low return on equity of -3.73% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| 2.60 | 2.70 | 3.35 | 4.06 | 3.76 | 1.14 | 0.96 | 0.36 | 0.57 | |
| 2.07 | 2.14 | 2.24 | 2.82 | 2.83 | 1.73 | 1.06 | 0.39 | 0.39 | |
| Operating Profit | 0.53 | 0.56 | 1.11 | 1.24 | 0.93 | -0.59 | -0.10 | -0.03 | 0.18 |
| OPM % | 20.38% | 20.74% | 33.13% | 30.54% | 24.73% | -51.75% | -10.42% | -8.33% | 31.58% |
| 0.14 | 0.05 | 0.07 | 0.14 | -0.54 | -0.01 | 0.00 | 0.01 | 0.15 | |
| Interest | 0.11 | 0.02 | 0.54 | 0.67 | 1.19 | 0.70 | 0.05 | 0.05 | 0.06 |
| Depreciation | 0.31 | 0.39 | 0.57 | 0.59 | 0.65 | 0.65 | 0.71 | 0.52 | 0.34 |
| Profit before tax | 0.25 | 0.20 | 0.07 | 0.12 | -1.45 | -1.95 | -0.86 | -0.59 | -0.07 |
| Tax % | 44.00% | 35.00% | 228.57% | 100.00% | 2.76% | 1.54% | 0.00% | -3.39% | -28.57% |
| 0.14 | 0.13 | -0.09 | 0.00 | -1.49 | -1.98 | -0.86 | -0.57 | -0.05 | |
| EPS in Rs | 0.09 | 0.09 | -0.06 | 0.00 | -0.99 | -1.31 | -0.57 | -0.38 | -0.03 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -32% |
| 3 Years: | -21% |
| TTM: | 58% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 25% |
| TTM: | 91% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 9% |
| 3 Years: | 69% |
| 1 Year: | 240% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -6% |
| 3 Years: | -4% |
| Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 |
| Reserves | 2.57 | 2.70 | 2.61 | 2.61 | 1.12 | -0.86 | -1.72 | -2.30 | -2.34 |
| 0.17 | 5.49 | 6.94 | 6.99 | 7.69 | 8.24 | 8.10 | 8.05 | 8.16 | |
| 0.45 | 0.45 | 0.63 | 0.86 | 0.79 | 0.82 | 0.83 | 0.82 | 0.75 | |
| Total Liabilities | 18.29 | 23.74 | 25.28 | 25.56 | 24.70 | 23.30 | 22.31 | 21.67 | 21.67 |
| 7.47 | 8.50 | 12.14 | 15.69 | 11.40 | 11.94 | 11.23 | 14.69 | 14.34 | |
| CWIP | 0.00 | 8.14 | 6.64 | 3.28 | 7.29 | 6.10 | 6.11 | 2.14 | 2.14 |
| Investments | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| 10.41 | 6.69 | 6.09 | 6.18 | 5.60 | 4.85 | 4.56 | 4.43 | 4.78 | |
| Total Assets | 18.29 | 23.74 | 25.28 | 25.56 | 24.70 | 23.30 | 22.31 | 21.67 | 21.67 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| 2.00 | 1.36 | 0.00 | 1.30 | 0.15 | 0.19 | -0.12 | |||
| -9.57 | -3.23 | 0.00 | -0.50 | -0.12 | -0.17 | 0.01 | |||
| 5.19 | 1.37 | 0.00 | -0.88 | -0.03 | -0.02 | 0.11 | |||
| Net Cash Flow | -2.38 | -0.50 | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 | ||
| Free Cash Flow | -7.56 | -1.35 | 0.00 | 1.23 | 0.16 | 0.19 | -0.11 | ||
| CFO/OP | 357% | 123% | 0% | 140% | -25% | -190% | -67% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 13.86 | 21.22 | 45.62 | 36.50 | 36.50 | 21.47 | |||
| Days Payable | 13.86 | 4.24 | 0.00 | 12.17 | 73.00 | 0.00 | |||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.90 | 16.98 | 45.62 | 24.33 | -36.50 | 21.47 |
| Working Capital Days | 1,037.44 | 462.33 | 306.16 | 265.21 | 245.60 | 582.72 | 589.32 | 1,449.86 | 1,171.84 |
| ROCE % | 1.07% | 2.54% | 3.20% | 1.15% | -5.33% | -3.67% | -2.54% | -0.05% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Medical Materials Consumed INR ・Standalone data |
|
|||||||||||
| Employee Benefit Expense INR ・Standalone data |
||||||||||||
| Gross Block of Medical & Diagnostic Equipment INR ・Standalone data |
||||||||||||
| Revenue from Diagnostic & Allied Services INR ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Draft Letter of Offer
1 Jun - Mandatory open offer filed for 26% stake in Dolphin Medical at ₹4.80 per share.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Submitted FY2026 annual secretarial compliance report; PCS confirmed full SEBI compliance.
-
Detailed Public Statement (Corrigendum)
23 May - Corrigendum to open offer for 39,25,988 shares at ₹4.80 each, acquiring 26% of Dolphin Medical Services.
-
Announcement under Regulation 30 (LODR)-Open Offer - Updates
23 May - Mandatory open offer for 39,25,988 shares at ₹4.80; acquirers to gain control after SPA.
-
Detailed Public Statement
23 May - Acquirers to buy 26% stake at ₹4.80/share; SPA signed May 15, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
a) DMSL provides a range of tests covering Radiology and Imaging, Biochemistry, Pathology, and Microbiology, etc., to the people of the coastal region of Andhra Pradesh.
b) Additionally, it has the eye care
division called the Dolphin Nethralaya
which is a comprehensive eye care
and a laser and research centre.
c) The company has also ventured
into IT and Biotechnology and Herbal
sectors